Search results for "Retinal"

showing 10 items of 631 documents

Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.

2012

Leber hereditary optic neuropathy (LHON) is a mitochondrially inherited form of visual dysfunction caused by mutations in several genes encoding subunits of the mitochondrial respiratory NADH-ubiquinone oxidoreductase complex (complex I). Development of gene therapies for LHON has been impeded by genetic heterogeneity and the need to deliver therapies to the mitochondria of retinal ganglion cells (RGCs), the cells primarily affected in LHON. The therapy under development entails intraocular injection of a nuclear yeast gene NADH-quinone oxidoreductase (NDI1) that encodes a single subunit complex I equivalent and as such is mutation independent. NDI1 is imported into mitochondria due to an e…

Oxidoreductase complexRetinal Ganglion CellsretinaSaccharomyces cerevisiae Proteinsgenetic structuresGenetic enhancementProtein subunitGenetic VectorsOptic Atrophy Hereditary LeberBiologyMitochondrionmedicine.disease_causeRetinal ganglionArticleMiceLHONGeneticsmedicineAnimalsHumansGenetics (clinical)GeneticsRetinaMutationElectron Transport Complex IGenetic heterogeneityAAVDependovirusgene therapyeye diseasesmitochondriaDisease Models AnimalOptic AtrophyNDI1medicine.anatomical_structureIntravitreal InjectionsCancer researchsense organsMicrotubule-Associated ProteinsEuropean journal of human genetics : EJHG
researchProduct

Differential Expression of the Demosponge (Suberites domuncula) Carotenoid Oxygenases in Response to Light: Protection Mechanism Against the Self-Pro…

2012

The demosponge Suberites domuncula has been described to contain high levels of a proteinaceous toxin, Suberitine, that displays haemolytic activityIn the present study this 7–8 kDa polypeptide has been isolated and was shown to exhibit also cytotoxic effects on cells of the same species. Addition of retinal, a recently identified metabolite of β-carotene that is abundantly present in S. domuncula was found to reduce both the haemolytic and the cell toxic activity of Suberitine at a molar ratio of 1:1. Spectroscopic analyses revealed that the interaction between β-carotene and Suberitine can be ascribed to a reversible energy transfer reaction. The enzyme that synthesises retinal in the spo…

OxygenaseLightMolecular Sequence DataPharmaceutical Sciencemedicine.disease_causeretinalArticle03 medical and health sciencesSuberitineDioxygenaseβ-caroteneDrug DiscoverymedicineAnimalsAmino Acid SequenceCloning Molecularlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Carotenoidsponges030304 developmental biologyβ-carotene dioxygenasechemistry.chemical_classification0303 health sciencesbiologyBacteriaToxinCarotenoid oxygenase030302 biochemistry & molecular biologyProteinsSuberitine; β-carotene; retinal; β-carotene dioxygenase; sponges; <em>Suberites domuncula</em>biology.organism_classificationSuberites domunculaSuberites domunculaEnzymelcsh:Biology (General)Biochemistrychemistrybiology.proteinOxygenasesRetinaldehydeSuberitesSuberitesMarine Drugs
researchProduct

A visual framework to create photorealistic retinal vessels for diagnosis purposes

2020

The methods developed in recent years for synthesising an ocular fundus can be been divided into two main categories. The first category of methods involves the development of an anatomical model of the eye, where artificial images are generated using appropriate parameters for modelling the vascular networks and fundus. The second type of method has been made possible by the development of deep learning techniques and improvements in the performance of hardware (especially graphics cards equipped with a large number of cores). The methodology proposed here to produce high-resolution synthetic fundus images is intended to be an alternative to the increasingly widespread use of generative ad…

PLUS DISEASEData augmentationFundus OculiComputer scienceCOMPUTER-AIDED DIAGNOSISIMAGESSEGMENTATIONComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONHealth InformaticsSynthetic retinal imageFundus (eye)Fundus image analysisStatistical featuresTORTUOSITY03 medical and health sciences0302 clinical medicineImage Processing Computer-AssistedComputer vision030212 general & internal medicineGraphics030304 developmental biologyGraphical user interfaceSettore ING-INF/05 - Sistemi Di Elaborazione Delle Informazioni0303 health sciencesSettore INF/01 - Informaticabusiness.industryDeep learningRetinal VesselsReal imageComputer Science ApplicationsPredictive evaluation diseasesFILTERA priori and a posterioriArtificial intelligencebusinessSYSTEMJournal of Biomedical Informatics
researchProduct

Beneficial Read-Through of aUSH1CNonsense Mutation by Designed Aminoglycoside NB30 in the Retina

2010

PURPOSE. The human Usher syndrome (USH) is the most frequent cause of inherited combined deaf-blindness. USH is clinically and genetically heterogeneous, assigned to three clinical types. The most severe type is USH1, characterized by profound inner ear defects and retinitis pigmentosa. Thus far, no effective treatment for the ophthalmic component of USH exists. The p.R31X nonsense mutation in USH1C leads to a disease causing premature termination of gene translation. Here, we investigated the capability of the novel synthetic aminoglycoside NB30 for the translational read-through of the USH1C-p.R31X nonsense mutation as a retinal therapy option. METHODS. Read-through of p.R31X by three com…

ParomomycinUsher syndromeBlotting WesternNonsense mutationCell Culture TechniquesGene ExpressionCell Cycle ProteinsParomomycinBiologyPharmacologyTransfectionRetinaMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRetinitis pigmentosaIn Situ Nick-End Labelingotorhinolaryngologic diseasesmedicineAnimalsHumansAdaptor Proteins Signal Transducing030304 developmental biologyGenetics0303 health sciencesRetinaDose-Response Relationship DrugAminoglycosideRetinalmedicine.disease3. Good healthMice Inbred C57BLCytoskeletal ProteinsAminoglycosidesElectroporationHEK293 Cellsmedicine.anatomical_structureMicroscopy FluorescencechemistryCodon NonsenseProtein BiosynthesisGentamicinGentamicins030217 neurology & neurosurgerymedicine.drugInvestigative Opthalmology &amp; Visual Science
researchProduct

Ahmed valve, suture-less implantation: A new approach to an easier technique.

2013

Purpose Tissue adhesives have been used in ophthalmology instead of sutures to minimize the operating time. This case series investigated the effectiveness and safety of use of cyanoacrylate in Ahmed valve implantation through pars plana for refractory glaucoma. Patients and methods Seventeen eyes of 17 patients with refractory glaucoma underwent Ahmed valve scleral suture-less implantation through pars plana with a cyanoacrylate suture of the plate. Refractory glaucoma was defined as intraocular pressure (IOP) ≥ 21 mm Hg with antiglaucoma eye drops, good adherence to treatment, and no previous glaucoma surgery. IOP control and development of complications were evaluated during the follow-u…

Pars planaAdultMalemedicine.medical_specialtyIntraocular pressureTime Factorsgenetic structuresAnterior Chambermedicine.medical_treatmentGlaucomaVitrectomyPilot ProjectsProsthesis ImplantationTonometry OcularPostoperative ComplicationsOphthalmologymedicineGlaucoma surgeryHumansCyanoacrylatesProspective StudiesGlaucoma Drainage ImplantsHyphemaIntraocular PressureAgedAged 80 and overbusiness.industrySuture TechniquesRetinal detachmentGlaucomaMiddle Agedmedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structureTreatment OutcomeVitreous hemorrhageFemalesense organsbusinessJournal of glaucoma
researchProduct

Delayed Suprachoroidal Hemorrhage After Pars Plana Vitrectomy: Five-Year Results of a Retrospective Multicenter Cohort Study

2015

Purpose To determine the incidence, risk factors, and outcomes of delayed suprachoroidal hemorrhage after vitrectomy. Design Retrospective multicenter cohort study. Methods All consecutive patients who underwent primary vitrectomy, from January 2009 to December 2014, at 4 tertiary vitreoretinal centers in Italy were enrolled. Patient demographics and systemic, ophthalmic, operative, and postoperative data from all centers were extracted from the electronic record system using standardized data collection forms. All eyes that developed delayed suprachoroidal hemorrhage within 48 hours of the end of the vitrectomy were identified as the delayed suprachoroidal hemorrhage group; all other eyes …

Pars planaChoroid HemorrhageMalemedicine.medical_specialtyTime FactorsTime FactorFundus Oculimedicine.medical_treatmentVitrectomyPostoperative HemorrhageChoroid hemorrhageFollow-Up StudieRetrospective StudieRisk FactorsOphthalmologyVitrectomymedicineHumansFluorescein AngiographyAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryRisk FactorRetinal DetachmentRetinal detachmentRetrospective cohort studyOdds ratioMiddle AgedFluorescein angiographymedicine.diseaseSurgeryOphthalmologymedicine.anatomical_structureFemalebusinessHumanCohort studyFollow-Up Studies
researchProduct

Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment

2020

The treatment for rhegmatogenous retinal detachment (RRD) is surgery, including pars plana vitrectomy (PPV) and scleral buckling (SB). Despite surgical advances, degeneration of the photoreceptors and post-operative complications, such as proliferative vitreoretinopathy (PVR), often occurs as the result of inflammation, preventing complete visual recovery or causing RRD recurrence. There is increasing evidence that in the presence of RRD, the activation of inflammatory processes occurs and the surgery itself induces an inflammatory response. This comprehensive review focuses on the use of different formulations of corticosteroids (CCS), as an adjunctive treatment to surgery, either PPV or S…

Pars planamedicine.medical_specialtyProliferative vitreoretinopathyTriamcinolone acetonidemedicine.medical_treatmentvitrectomylcsh:MedicineVitrectomydexamethasoneReviewtriamcinolonecorticosteroids03 medical and health sciences0302 clinical medicinefluocinolonecorticosteroids; dexamethasone; fluocinolone; rhegmatogenous retinal detachment; scleral buckling; triamcinolone; vitrectomyPrednisoneMedicineCorticosteroidscleral bucklingSettore MED/30 - Malattie Apparato Visivobusiness.industrylcsh:Rrhegmatogenous retinal detachmentRetinal detachmentGeneral MedicineFluocinolonemedicine.diseaseeye diseasesSurgerymedicine.anatomical_structureAdjunctive treatment030221 ophthalmology & optometrybusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Endogene Candida-Endophthalmitis bei Patienten mit schweren Allgemeinerkrankungen

2005

Background: Endogenous Candida endophthalmitis is a rare disease with increasing frequency and poor prognosis. Patients and Methods: The course of endogenous Candida endophthalmitis in 7 eyes of 5 patients (age 2 months to 76 years) was evaluated. Underlying general diseases were diagnosed as colon cancer, diverticulitis, pancreatic insufficiency (with subclavian catheter), ileus and diabetes mellitus. Diagnosis was based on the very typical ocular feature combined with a positive blood or vitreous culture. Intensive antimycotic drug therapy was initiated and pars plana vitrectomy performed as soon as possible. Results: The delay between onset of ocular symptoms and diagnosis amounted to on…

Pars planamedicine.medical_specialtyVisual acuitygenetic structuresIleusbusiness.industrymedicine.medical_treatmentRetinal detachmentVitrectomyDiverticulitismedicine.diseaseeye diseasesSurgeryOphthalmologymedicine.anatomical_structurePharmacotherapyOphthalmologymedicinesense organsmedicine.symptombusinessRare diseaseKlinische Monatsblätter für Augenheilkunde
researchProduct

Pars-Plana-Vitrektomie bei diabetischen Traktionsamotiones mit Foramen

2000

PURPOSE: To evaluate results and prognostic factors of pars-plana vitrectomy (ppv) using membrane peeling and C2F6-gas for diabetic traction retinal detachments with a hole. METHODS: We retrospectively reviewed the healing course of 84 eyes, which were treated in this way consecutively (follow-up 6-32 month). C2F6 was always used in case of a retinal hole at the posterior pole or in the upper part of the eye. The influence of HBA1c, type of diabetes, preoperative visual acuity, preoperative laser-coagulation and macular status over treatment results and rate of complications were studied using multivariate logistic regression analysis. RESULTS: Preoperatively 56% of the eyes showed premacul…

Pars planamedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industrymedicine.medical_treatmentPosterior poleRetinal perforationRetinal detachmentVitrectomyDiabetic retinopathymedicine.diseaseeye diseasesOphthalmologymedicine.anatomical_structureOphthalmologyVitreous hemorrhagemedicinesense organsmedicine.symptombusinessKlinische Monatsblätter für Augenheilkunde
researchProduct

Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial de las membranas epirretinianas maculares y el síndrom…

2009

espanolObjetivo: Determinar si la inyeccion intravitrea de plasmina es efectiva en el tratamiento de las membranas epirretinianas maculares (MEM) y el sindrome de traccion vitreomacular (STVM), sin necesidad de asociar vitrectomia quirurgica. Material y metodo Diseno: Estudio piloto prospectivo, de intervencion, serie de casos. Pacientes: Siete pacientes, cuatro con membrana epirretiniana macular y tres con sindrome de traccion vitreomacular. Tratamiento: Inyeccion intravitrea de 0,2 ml de plasmina autologa bajo anestesia topica. La plasmina fue obtenida por un metodo simplificado modificado por adiccion de uroquinasa. Principales medidas: Grado de separacion de la membrana epirretiniana de…

Pars planamedicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentVitrectomyAgudeza visualTopical anesthesiaOphthalmologyMedicinevitreolisis enzimáticabusiness.industryRetinal tractionOutcome measuressíndrome de tracción vitreomacularmembrana epirretinianaSindrome devitrectomía enzimáticaeye diseasesSurgeryvitreolisis farmacológicaOphthalmologymedicine.anatomical_structurePlasmina autólogasense organsmedicine.symptombusinessArchivos de la Sociedad Española de Oftalmología
researchProduct